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Objective: The genital mycoplasmas, Ureaplasma urealyticum and Mycoplasma hominis, are commonly identiﬁed
in the vagina of healthy pregnant women. However, these microorganisms are the most common isolates from
the amniotic ﬂuids of women in preterm labor. The mechanisms responsible for vaginal colonization and ascent
to the uterus remain undetermined. We evaluated the association between U. urealyticum and M. hominis
vaginal colonization and the presence of pro-inﬂammatory and anti-inﬂammatory interleukin-1 system
components in asymptomatic pregnant women of different ethnicities.
Methods: Vaginal specimens, obtained from 224 ﬁrst trimester pregnant women, were assayed for interleukin-
1b (IL-1b) and IL-1 receptor antagonist (IL-1ra) concentrations by ELISA. U. urealyticum and M. hominis vaginal
colonization were identiﬁed by polymerase chain reaction (PCR).
Results: Vaginal colonization with M. hominis was identiﬁed in 37 (16.5%) women, and was more prevalent in
black (18.9%) and Hispanic (20.9%) than in white (4.2%) women (p=0.01). U. urealyticum was present in 84
(37.5%) women and there was no ethnic disparity in its detection. M. hominis colonization was associated with
elevated median vaginal IL-1b concentrations in both black women (p=0.02) and Hispanic women
(p=0.04), and was unrelated to vaginal IL-1ra concentrations. In marked contrast, U. urealyticum colonization
was associated with elevations in vaginal IL-1ra levels, but not with IL-1b concentrations, in black women
(p=0.02) and Hispanic women (p50.0001) and marginally in white women (p=0.06).
Conclusion: M. hominis colonization in healthy pregnant women is associated with localized pro-inﬂammatory
immune activation, while U. urealyticum colonization is associated with immune suppression.
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INTRODUCTION
Mycoplasma hominis and Ureaplasma urealyticum are
frequent colonizers of the vagina during preg-
nancy
1–4. In most women the presence of these
microorganisms is without apparent effect on
pregnancy outcome. In some women, however,
M. hominis and U. urealyticum ascend to the
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nancy, where they may contribute to preterm
labor and neonatal morbidity. U. urealyticum and
M. hominis are the microorganisms most fre-
quently cultured from amniotic ﬂuids of women
in preterm labor
5,6. A recent study demonstrated
an association between U. urealyticum in second
trimester amniotic ﬂuids and a subsequent
increased rate of premature rupture of fetal
membranes (PPROM) and preterm labor and
delivery
7.
The host factors associated with M. hominis and
U. urealyticum vaginal colonization and migration
to the upper genital tract in some women but not
in others have not been extensively examined.
Ureaplasma urealyticum vaginal colonization in
pregnant women has been related to elevated
vaginal concentrations of interleukin-1 receptor
antagonist (IL-1ra)
4. IL-1ra is an anti-inﬂamma-
tory cytokine and a natural competitive inhibitor
of the pro-inﬂammatory cytokine, interleukin-1b
(IL-1b)
8. Anti-microbial cell-mediated immune
defenses are initiated by IL-1b production
9.
The aim of the present study was to perform a
direct comparison, in a group of pregnant women
of known ethnic backgrounds, of the relationship
between M. hominis and U. urealyticum vaginal
colonization and vaginal IL-1b and IL-1ra con-
centrations.
MATERIAL AND METHODS
Subjects
A total of 224 consecutive ﬁrst trimester black,
Hispanic and white pregnant women from the
outpatient obstetrics clinic at The New York
Presbyterian Hospital, Weill Medical College of
Cornell University, with no known pregnancy
complications were studied. Ninety of the
women (40.2%) were black, 86 (38.4%) were
Hispanic and 48 (21.4%) were white and of
European background. The median ages of the
subjects were 25 years (range 15–44 years) for
black participants, 26 years (range 14–42 years) for
Hispanic participants and 28 years (range 19–39
years) for white participants. The difference in
ages between groups was not signiﬁcant
(p=0.07). All subjects participated in the New
York State Prenatal Care Assistance Program for
low income women. Each subject underwent a
complete physical examination that included
testing for Chlamydia trachomatis and Neisseria
gonorrhoeae by DNA hybridization, bacterial
vaginosis by clinical criteria and other microbial
pathogens by standard techniques. Infections were
diagnosed in 34 (15.2%) of the subjects. This
included 16 women with bacterial vaginosis, eight
with C. trachomatis, four with N. gonorrhoeae, and
two each with syphilis, Candida albicans or urinary
tract infections. All were treated and were
asymptomatic at the time of specimen collection.
Six (2.7%) women subsequently developed pre-
term premature rupture of fetal membranes and
14 (6.3%) delivered preterm (537 weeks).
This study was approved by the Institutional
Review Board of The New York Presbyterian
Hospital-Weill Cornell Medical Center.
Specimens
Specimens were obtained from the posterior
vaginal walls with a cotton swab and deposited
into a test tube containing phosphate-buffered
saline. The specimens were kept at 4
oC and
transported to the laboratory within 3–4 h. In the
laboratory as much liquid as possible was extruded
from the swabs. Supernatant and pellet fractions
were obtained by microcentrifugation and stored
separately at –80
oC until tested.
Detection of M. hominis
An aliquot of the pellet fraction from each subject
was tested for M. hominis by a published
polymerase chain reaction protocol employing
primer-pairs speciﬁc for a 324 base pair region of
the 16S ribosomal RNA gene
10, except that
digoxigenin-labeled dUTP was added to the
reaction mixture. To insure speciﬁcity, the
PCR amplicons were hybridized to a biotinylated
oligonucleotide internal probe (5
1-biotin-GCC
CAC CAA GAC TAT GAT GTT TAG-3
1) and
the complex detected in duplicate by ELISA
utilizing streptavidin-coated wells of a microtiter
plate and peroxidase-labeled anti-digoxigenin
antibody (Roche Diagnostics, Mannheim, Ger-
many). Puriﬁed M. hominis was always processed
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positive control. H2O blanks served as negative
controls.
Detection of U. urealyticum
An aliquot of the pellet fraction was analyzed for
U. urealyticum by a published PCR protocol
11,
utilizing digoxigenin-labelled dUTP and primer
pairs speciﬁc for a 429 base pair region of the
urease gene. Analysis was as described above for
M. hominis, using 5’-biotin- GAG ATA ATG
ATT ATA TGT CAG GAT CA-3’ as the
biotinylated internal probe. Puriﬁed U. urealyti-
cum was always processed and analyzed in parallel
to the test samples as a positive control. H2O
blanks served as negative controls.
Vaginal IL-1ra and IL-1b protein concentrations
The thawed supernatant fractions were tested in
duplicate for IL-1ra and IL-1b concentrations by
commercial ELISA assays (BioSource Interna-
tional, Camarillo, CA). The mean optical density
values were converted to ng/ml (IL-1ra) or pg/ml
(IL-1b) by reference to a standard curve utilizing
puriﬁed cytokines. The lower limit of detection
of the assay was 4 pg/ml for IL-1ra and 1 pg/ml
for IL-1b.
Statistics
Differences in IL-1b and IL-1ra levels between
groups were non-randomly distributed and ana-
lyzed by the non-parametric Mann-Whitney test.
Comparisons between discrete variables were
analyzed by Fisher’s exact test. A p value 50.05
was considered signiﬁcant.
RESULTS
Detection of M. hominis and U. urealyticum in
vaginal samples from pregnant women
M. hominis was detected in 37 (16.5%) of the
women tested, while U. urealyticum was identiﬁed
in 84 (37.5%) women. The relation between M.
hominis and U. urealyticum detection and subjects’
ethnicity is shown in Table 1. M. hominis was
identiﬁed in 20.9% of the Hispanic women and
18.9% of the black women, but in only 4.2% of
the white subjects (p=0.01). In contrast, U.
urealyticum colonization was unrelated to ethni-
city. Hispanic women positive for M. hominis
were considerably younger (median of 21 years of
age) than Hispanic women who were negative
(median of 27 years of age) for this mycoplasma
(p=0.001). There was no relationship between
M. hominis colonization and age in the black and
white populations, or between U. urealyticum
colonization and any of the three ethnic groups.
M. hominis and U. urealyticum colonization and
vaginal cytokine levels
The relation between M. hominis or U. urealyticum
vaginal colonization and vaginal concentrations of
IL-1ra and IL-1b was analyzed. M. hominis
colonization was associated with elevated vaginal
IL-1b levels in the subjects as a whole (p=0.007)
and in both blacks subjects (p50.02) and
Hispanic subjects (p=0.04), and a markedly
decreased IL-1ra to IL-1b ratio. The number of
white women who were M. hominis-positive was
too few to analyze. In contrast, there was no
relation between the presence of M. hominis and
vaginal IL-1ra concentration (Table 2).
U. urealyticum colonization was associated with
elevated vaginal IL-1ra levels in the study
population as a whole (p50.0001), as well as
in black women (p50.02) and Hispanic women
(p=0.002) (Table 3). IL-1ra was also elevated in
whites women that were positive for U. urealy-
ticum, but this did not reach statistical signiﬁcance
(p=0.06). U. urealyticum colonization was un-
related to vaginal IL-1b levels in all groups; the
Table 1 Relation between ethnicity and vaginal coloni-
zation with M. hominis and U. urealyticum
No. (%) positive
Ethnic group No. women M. hominis U. urealyticum
Black 90 17 (18.9) 30 (33.3)
Hispanic 86 18 (20.9) 38 (44.2)
White 48 2 (4.2)
a 16 (33.3)
ap=0.01 vs. black and Hispanic women
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presence of U. urealyticum.
There were no signiﬁcant differences in the
vaginal concentrations of IL-1b and IL-1ra
between the different ethnic groups. Among the
17 women positive for both mycoplasmas the
median vaginal concentration of IL-1b was
elevated (31.2 pg/ml) as compared to those
positive only for U. urealyticum (p=0.02). Simi-
larly, median vaginal IL-1ra levels were higher
(550 ng/ml) as compared to those positive only
for M. hominis (p=0.006).
There was no apparent relationship between
U. urealyticum and M. hominis vaginal coloniza-
tion. Among black subjects, U. urealyticum was
detected in 7 of 17 (41.2%) women who were
positive for M. hominis. Similarly, among
Hispanic subjects, 10 of the 18 women (55.6%)
with M. hominis were also positive for U.
urealyticum. There was no relationship between
detection of M. hominis or U. urealyticum and a
prior treated bacterial vaginosis or any other
infection.
M. hominis and U. urealyticum colonization and
pregnancy outcome
The 14 women in our study who delivered
preterm (6.3%), were too few to determine if
there was an association between pregnancy
outcome and mycoplasmal vaginal colonization.
However, the rate of preterm birth was highest
when M. hominis was present either alone or in
conjunction with U. urealyticum. A preterm birth
was documented in 7.3% of women who were
positive only for U. urealyticum, 11.1% positive
only for M. hominis, 11.8% positive for both
microorganisms and 6.7% who were negative for
both mycoplasmas.
DISCUSSION
The delineation of immune factors associated
with vaginal colonization by individual micro-
organisms in healthy pregnant women has
received scant research attention. Since both M.
hominis and U. urealyticum have been implicated in
Table 2 Relation between M. hominis vaginal colonization, ethnicity and vaginal concentrations of IL-1b and IL-1ra
Ethnic group Microorganism Median IL-1b (range) Median IL-1ra (range)
All M. hominis (+) 19.8pg/ml (0–440) 350 ng/ml (35–1800)
M. hominis (7) 9.2 pg/ml (0–448)
a 275 ng/ml (0–1900)
Black M. hominis (+) 22.6 pg/ml (13.7–184)
b 337 ng/ml (75–1800)
M. hominis (7) 9.6 pg/ml (12.8–204) 250 ng/ml (10–1900)
Hispanic M. hominis (+) 17.7 pg/ml (0–440)
c 425 ng/ml (35–1800)
M. hominis (7) 7.8 pg/ml (0–448) 287 ng/ml (0–1900)
ap=0.007,
bp=0.02,
cp=0.04 vs. M. hominis (7)
Table 3 Relation between U. urealyticum vaginal colonization, ethnicity and vaginal concentrations of IL-1b and IL-1ra
Ethnic group Microorganism Median IL-1b (range) Median IL-1ra (range)
All U. urealyticum (+) 12.7 pg/ml (0–372) 550 ng/ml (35–2000)
a
U. urealyticum (7) 9.2 pg/ml (0–364) 250 ng/ml (10–1800)
Black U. urealyticum (+) 15.2 pg/ml (0–204) 374 ng/ml (60–1900)
b
U. urealyticum (7) 11.8 pg/ml (0–148) 237 ng/ml (10–1800)
Hispanic U. urealyticum (+) 10.7 pg/ml (0–372) 672 ng/ml (35–1800)
c
U. urealyticum (7) 8.8 pg/ml (0–242) 250 ng/ml (10–1800)
White U. urealyticum (+) 21.8 pg/ml (4–148) 340 ng/ml (90–2000)
d
U. urealyticum (7) 9.2 pg/ml (0–364) 200 ng/ml (0–1800)
ap50.0001,
bp=0.02,
cp=0.002,
dp=0.06
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understand the factors involved in their coloniza-
tion of the vagina. The results of the present study
suggest that M. hominis and U. urealyticum differ in
their immune responses in the vagina of pregnant
women. Speciﬁcally, M. hominis vaginal coloniza-
tion was associated with elevated vaginal IL-1b
concentrations and unchanged IL-1ra levels,
while the reverse was true for U. urealyticum
colonization.
Differences between M. hominis and U.
urealyticum in relation to vaginal colonization
and pathogenic effects, and which may reﬂect
their differential effect on induction of IL-1
system components, have been noted by other
investigators. Carriage of the speciﬁc genotype of
the polymorphic IL-1ra gene that is associated
with elevated IL-1ra production appears to
inﬂuence the rate of U. urealyticum vaginal
colonization
4, but not M. hominis colonization
12.
In both asymptomatic pregnant and non-preg-
nant women, U. urealyticum vaginal colonization
is much more prevalent than is M. hominis
colonization
3,13–15. This might reﬂect the cap-
ability of U. urealyticum, but not M. hominis, to
inhibit the local pro-inﬂammatory immune
response. Conversely, there is an increase in
the rate of vaginal M. hominis colonization, but
not U. urealyticum colonization, in association
with bacterial vaginosis, or Trichomonas vaginalis
or C. trachomatis infections
16,17. Immune system
alterations induced by pathogenic microorgan-
isms may alter local immune defense mechanisms
and thereby selectively enhance the likelihood of
M. hominis colonization and proliferation. It has
also been suggested that M. hominis magniﬁes the
effects of other sexually transmitted infections
17.
Our observation that M. hominis is associated
with a pro-inﬂammatory immune response, i.e.
elevated vaginal IL-1b concentration, in the
vagina of healthy asymptomatic women suggests
that the enhanced proliferation of this myco-
plasma in conjunction with other infections
results in increased vaginal inﬂammation. It
might also be relevant that the ability of M.
hominis but not U. urealyticum, to induce the
release of high levels of histamines, a potent
inducer of inﬂammation, from rat mast cells has
been noted
18.
The inﬂuence of M. hominis and U. urealyticum
on neonatal pathology also appears to differ.
Tracheal aspirates of preterm infants are fre-
quently colonized with U. urealyticum, without
any apparent effect on the rate of bronchopul-
monary dysplasia
19 or chronic lung disease
20.I n
one study, the presence of U. urealyticum in
tracheal aspirates was actually associated with a
reduced rate of cystic periventricular leukomala-
cia
21. Colonization of the placenta by U.
urealyticum was shown to be unrelated to an
increased rate of cerebral damage in preterm
infants, while the presence of placental M. hominis
was associated with a three-fold increased risk of
echolucency
22. The present data support the
suggestion by Dammann et al. that U. urealyticum
may be a marker for decreased inﬂammatory
capability
22.
Our previous study
4 and the present investiga-
tion noted no racial differences between white
and non-white subjects in U. urealyticum coloni-
zation rates. In the present study M. hominis was
predominantly detected in non-white women.
Racial disparities in microbial vaginal coloniza-
tion have been reported previously
17,23,24. A prior
study of microbial colonization in black and
Hispanic women with a concurrent sexually
transmitted infection found M. hominis coloniza-
tion to be associated with the black race
21. There
are two major differences between this investiga-
tion and our study. Beside the absence of sexually
transmitted diseases in our population, the
Hispanic women analyzed in our study were
from Puerto Rico and other Caribbean islands,
while in the previous study the Hispanics were of
Mexican ancestry.
The rate of adverse pregnancy outcome in this
cohort of patients was not outside the expected
range for this population. The number of patients
was insufﬁcient to be able to comment on
whether mycoplasmal vaginal colonization was
associated with an increased rate of any adverse
pregnancy outcome. In addition, our PCR
analysis was only qualitative and not quantitative.
Thus, the present study suggests that M.
hominis colonization may be recognized by the
immune system in the vagina of pregnant women
and results in the induction of pro-inﬂammatory
immunity, while U. urealyticum colonization is
M. hominis, U. urealyticum and vaginal cytokines Doh et al.
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tory cytokine, IL-1ra. Further investigations are
needed, however, to deﬁnitively differentiate
between a direct effect of these microorganisms
on vaginal cytokine levels or whether M. hominis
and/or U. urealyticum colonization is increased
under conditions when immunity in the vaginal
milieu is altered due to the presence of other
infectious agents or non-infectious factors. Con-
ditions that inhibit pro-inﬂammatory immunity
may lead to increased colonization/proliferation
by U. urealyticum, and thereby enhance their
capacity to ascend to the endometrium and cause
clinical disease.
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